Skip to content

ZIEZONDER

Active
Private limited companyfounded 2023active for 3 yearsTongersestraat 106, 3740 Bilzen-Hoeselt, BelgiumKBO/BCE: BE 0801.197.333

From the official registers: KBO 2 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

ZIEZONDER has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €238,830 and a net result of €565,647. Its solvency ranks better than 15% of 3,023 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
ZIEZONDERActiveChecked score 94/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 26-04-2023 Normal situation
Legal form
Private limited company
Registered office
Tongersestraat 106, 3740 Bilzen-Hoeselt
Activity
Specialist medical practice NACE 86220
Establishment unit
2.347.338.929 3740 Bilzen-Hoeselt, since 26-04-2023
Financial year end
31 December
Peppol
Reachable since 16-07-2026
Company details

Who decides

Board
Shareholders
Board & ownership

How it is doing

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€1.3m
▲ 159%
Turnover
≈ €1.1m
estimated
Profit
€565,647
▲ 781%
Equity
€238,830
▲ 245%
Total assets
€2.1m
▲ 7.0%
Staff
3.6 FTE
▲ 63.6%
2025 accounts 36 days early
Filed on 25-06-2026at the National Bank
Financials
Why 94raises riskEquity €238,830 (11.4% of total assets)lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed 25-06-2026)Size: 3.6 FTE, total assets €2.1mShow the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 55% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 36+7
equity 11.4% of total assets
Liquidity 53-2
short-term debt 41.2% · cash 18.1%
Profitability 100+27
return on assets 27.0%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: 0.7% 12-2024: 0.7%● unchanged vs 11-2024 01-2025: 0.8%▲ +0.1 percentage points vs 12-2024 02-2025: 0.7%▼ -0.1 percentage points vs 01-2025 03-2025: 0.8%▲ +0.1 percentage points vs 02-2025 04-2025: 0.8%● unchanged vs 03-2025highest value 05-2025: 0.8%● unchanged vs 04-2025highest value 06-2025: 0.8%● unchanged vs 05-2025highest value 07-2025: 0.8%● unchanged vs 06-2025highest value 08-2025: 0.2%▼ -0.6 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.3%▲ +0.1 percentage points vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.1%▼ -0.2 percentage points vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026lowest value
Credit of up to €22,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.56, compared with 0.54 in 2024, below 1; short-term debt: 41.2% and cash: 18.1% of total assets), and 88.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 15% on solvency, 27% on liquidity, 80% on profitability and 96% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Figures for financial year 2025 (filed 25-06-2026)
NBB · annual accounts
raises risk · Equity €238,830 (11.4% of total assets)
NBB · annual accounts
lowers risk · Size: 3.6 FTE, total assets €2.1m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 3023 sector peers (2025).
NBB · sector comparison
Position among 3023 sector peers
Solvency
better than 15%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-06-2026, 36 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
36 days early
2024
3 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 20 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage

Key points

  • Positive: Result rose in 2025from €64,182 to €565,647 ▲ 781% View
  • Caution: Among the weakest 16% on solvencysector median 59.2% · 3,023 companies 11.4% View

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about ZIEZONDER

What is the company number of ZIEZONDER?
0801.197.333. In Belgium the VAT number is the company number with BE in front: BE 0801.197.333.
Where is ZIEZONDER based?
The registered office is at Tongersestraat 106, 3740 Bilzen-Hoeselt.Company details
What does ZIEZONDER do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ZIEZONDER?
Private limited company (BV).
When was ZIEZONDER founded?
On 26-04-2023.
Is ZIEZONDER still active?
Yes, ZIEZONDER is an active enterprise in the KBO register.
How many employees does ZIEZONDER have?
On average 3.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of ZIEZONDER?
≈ €1.1m in financial year 2025. Estimated from the gross margin of €1.3m: probably between €1.0m and €1.6m, based on 64 comparable companies, NACE 86.
Is ZIEZONDER profitable?
In financial year 2025, ZIEZONDER made a profit of €565,647.
Where can I find the annual accounts of ZIEZONDER?
ZIEZONDER filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of ZIEZONDER due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to ZIEZONDER

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure